NORAD and cancer: Based on the assessment of data available in The Cancer Genome Atlas (TCGA) as well as an independent cohort of patients with endometrial cancer, expression of NORAD has been decreased in endometrial cancer samples compared with normal tissue samples in association with cancer progression.